These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
543 related articles for article (PubMed ID: 32409880)
1. Congenital Conditions of Hypophosphatemia Expressed in Adults. Marcucci G; Brandi ML Calcif Tissue Int; 2021 Jan; 108(1):91-103. PubMed ID: 32409880 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets. Baroncelli GI; Grandone A; Aversa A; Sessa MR; Pelosini C; Michelucci A; Toschi B; Manca M; Isola A; Comberiati P Eur J Med Genet; 2024 Aug; 70():104958. PubMed ID: 38950880 [TBL] [Abstract][Full Text] [Related]
3. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment. Kinoshita Y; Fukumoto S Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients. Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081 [TBL] [Abstract][Full Text] [Related]
5. X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience. Bacchetta J; Rothenbuhler A; Gueorguieva I; Kamenicky P; Salles JP; Briot K; Linglart A Joint Bone Spine; 2021 Oct; 88(5):105208. PubMed ID: 34102329 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries. Al Juraibah F; Al Amiri E; Al Dubayee M; Al Jubeh J; Al Kandari H; Al Sagheir A; Al Shaikh A; Beshyah SA; Deeb A; Habeb A; Mustafa M; Zidan H; Mughal MZ Arch Osteoporos; 2021 Mar; 16(1):52. PubMed ID: 33660084 [TBL] [Abstract][Full Text] [Related]
7. New Therapies for Hypophosphatemia-Related to FGF23 Excess. Athonvarangkul D; Insogna KL Calcif Tissue Int; 2021 Jan; 108(1):143-157. PubMed ID: 32504139 [TBL] [Abstract][Full Text] [Related]
8. Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium. Laurent MR; De Schepper J; Trouet D; Godefroid N; Boros E; Heinrichs C; Bravenboer B; Velkeniers B; Lammens J; Harvengt P; Cavalier E; Kaux JF; Lombet J; De Waele K; Verroken C; van Hoeck K; Mortier GR; Levtchenko E; Vande Walle J Front Endocrinol (Lausanne); 2021; 12():641543. PubMed ID: 33815294 [TBL] [Abstract][Full Text] [Related]
9. Phosphatonins: From Discovery to Therapeutics. Kritmetapak K; Kumar R Endocr Pract; 2023 Jan; 29(1):69-79. PubMed ID: 36210014 [TBL] [Abstract][Full Text] [Related]
10. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. Insogna KL; Briot K; Imel EA; Kamenický P; Ruppe MD; Portale AA; Weber T; Pitukcheewanont P; Cheong HI; Jan de Beur S; Imanishi Y; Ito N; Lachmann RH; Tanaka H; Perwad F; Zhang L; Chen CY; Theodore-Oklota C; Mealiffe M; San Martin J; Carpenter TO; J Bone Miner Res; 2018 Aug; 33(8):1383-1393. PubMed ID: 29947083 [TBL] [Abstract][Full Text] [Related]
11. Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review. Jurca CM; Iuhas O; Kozma K; Petchesi CD; Zaha DC; Bembea M; Jurca S; Paul C; Jurca AD Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011303 [TBL] [Abstract][Full Text] [Related]
12. FGF23 and Associated Disorders of Phosphate Wasting. Gohil A; Imel EA Pediatr Endocrinol Rev; 2019 Sep; 17(1):17-34. PubMed ID: 31599133 [TBL] [Abstract][Full Text] [Related]
13. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. Ichikawa S; Austin AM; Gray AK; Econs MJ J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791 [TBL] [Abstract][Full Text] [Related]
14. Mineralized tissues in hypophosphatemic rickets. Robinson ME; AlQuorain H; Murshed M; Rauch F Pediatr Nephrol; 2020 Oct; 35(10):1843-1854. PubMed ID: 31392510 [TBL] [Abstract][Full Text] [Related]
15. X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management. Baroncelli GI; Mora S Front Endocrinol (Lausanne); 2021; 12():688309. PubMed ID: 34421819 [TBL] [Abstract][Full Text] [Related]
16. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study). Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300 [TBL] [Abstract][Full Text] [Related]
17. Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3'-UTR change as a possible cause. Sawatsubashi S; Takashi Y; Endo I; Kondo T; Abe M; Matsumoto T; Fukumoto S Bone; 2024 May; 182():117057. PubMed ID: 38412893 [TBL] [Abstract][Full Text] [Related]
18. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.]. Kinoshita Y Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120 [TBL] [Abstract][Full Text] [Related]
19. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets. Razali NN; Hwu TT; Thilakavathy K J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638 [TBL] [Abstract][Full Text] [Related]